Literature DB >> 19538200

Histamine-N-methyl transferase polymorphism and risk for multiple sclerosis.

E García-Martín1, C Martínez, J Benito-León, P Calleja, M Díaz-Sánchez, D Pisa, H Alonso-Navarro, L Ayuso-Peralta, D Torrecilla, J A G Agúndez, F J Jiménez-Jiménez.   

Abstract

BACKGROUND: Histamine N-methyltransferase (HNMT) is the main metabolizing enzyme of histamine (a mediator of inflammation implicated in the pathogenesis of multiple sclerosis-MS) in the CNS. We have investigated the possible association between a single nucleotide polymorphism of the HNMT (chromosome 2q22.1), that causes the amino acid substitution Thr105Ile (decreasing enzyme activity) and the risk for MS.
METHODS: We studied the frequency of the HNMT genotypes and allelic variants in 228 MS patients and 295 healthy controls using a PCR-RLFP method.
RESULTS: The frequencies of the HNMT genotypes and allelic variants did not differ significantly between MS patients and controls, and were unrelated with the age of onset of MS, gender, and course of MS.
CONCLUSION: The HNMT polymorphism is not related with the risk for MS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19538200     DOI: 10.1111/j.1468-1331.2009.02720.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  6 in total

1.  Thr105Ile (rs11558538) polymorphism in the histamine-1-methyl-transferase (HNMT) gene and risk for restless legs syndrome.

Authors:  Félix Javier Jiménez-Jiménez; Elena García-Martín; Hortensia Alonso-Navarro; Carmen Martínez; Martín Zurdo; Laura Turpín-Fenoll; Jorge Millán-Pascual; Teresa Adeva-Bartolomé; Esther Cubo; Francisco Navacerrada; Ana Rojo-Sebastián; Lluisa Rubio; Sara Ortega-Cubero; Pau Pastor; Marisol Calleja; José Francisco Plaza-Nieto; Belén Pilo-de-la-Fuente; Margarita Arroyo-Solera; Esteban García-Albea; José A G Agúndez
Journal:  J Neural Transm (Vienna)       Date:  2016-11-11       Impact factor: 3.575

2.  Repurposing Histaminergic Drugs in Multiple Sclerosis.

Authors:  Susanna Amadio; Federica Conte; Giorgia Esposito; Giulia Fiscon; Paola Paci; Cinzia Volonté
Journal:  Int J Mol Sci       Date:  2022-06-06       Impact factor: 6.208

3.  NQO1 gene rs1800566 variant is not associated with risk for multiple sclerosis.

Authors:  José A G Agúndez; Elena García-Martín; Carmen Martínez; Julián Benito-León; Jorge Millán-Pascual; Patricia Calleja; María Díaz-Sánchez; Diana Pisa; Laura Turpín-Fenoll; Hortensia Alonso-Navarro; Lucía Ayuso-Peralta; Dolores Torrecillas; José Francisco Plaza-Nieto; Félix Javier Jiménez-Jiménez
Journal:  BMC Neurol       Date:  2014-04-23       Impact factor: 2.474

4.  Heme Oxygenase-1 and 2 Common Genetic Variants and Risk for Multiple Sclerosis.

Authors:  José A G Agúndez; Elena García-Martín; Carmen Martínez; Julián Benito-León; Jorge Millán-Pascual; María Díaz-Sánchez; Patricia Calleja; Diana Pisa; Laura Turpín-Fenoll; Hortensia Alonso-Navarro; Pau Pastor; Sara Ortega-Cubero; Lucía Ayuso-Peralta; Dolores Torrecillas; Esteban García-Albea; José Francisco Plaza-Nieto; Félix Javier Jiménez-Jiménez
Journal:  Sci Rep       Date:  2016-02-12       Impact factor: 4.379

5.  LINGO1 rs9652490 and rs11856808 polymorphisms are not associated with risk for multiple sclerosis.

Authors:  Elena García-Martín; Oswaldo Lorenzo-Betancor; Carmen Martínez; Pau Pastor; Julián Benito-León; Jorge Millán-Pascual; Patricia Calleja; María Díaz-Sánchez; Diana Pisa; Laura Turpín-Fenoll; Hortensia Alonso-Navarro; Lucía Ayuso-Peralta; Dolores Torrecillas; Elena Lorenzo; José Francisco Plaza-Nieto; José A G Agúndez; Félix Javier Jiménez-Jiménez
Journal:  BMC Neurol       Date:  2013-04-10       Impact factor: 2.474

6.  Histamine N-methyltransferase regulates aggression and the sleep-wake cycle.

Authors:  Fumito Naganuma; Tadaho Nakamura; Takeo Yoshikawa; Tomomitsu Iida; Yamato Miura; Anikó Kárpáti; Takuro Matsuzawa; Atushi Yanai; Asuka Mogi; Takatoshi Mochizuki; Nobuyuki Okamura; Kazuhiko Yanai
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.